
According to data from Benzinga Pro, during Q4, Precigen's (NASDAQ:PGEN) reported sales totaled $24.22 million. Despite a 15.89% increase in earnings, the company posted a loss of $25.03 million. Precigen collected $21.56 million in revenue during Q3, but reported earnings showed a $29.76 million loss.